Orforglipron in Weight Management:
A Professional
Education Webinar

Professor Alexander Miras

Professor of Endocrinology, Ulster University

Professor Miras is an academic clinician and researcher in obesity medicine, endocrinology and metabolic disease. He is a recognised authority on pharmacological obesity management in the UK.

Current UK regulatory and licensed-use context

Where orforglipron sits within the current UK regulatory landscape and what licensed use currently looks like.

Published evidence and professional considerations

A review of the published trial data and what it means in practice for prescribers.

Clinical questions around assessment and monitoring

Practical clinical questions relevant to professional discussion on patient assessment and ongoing monitoring.

Administration and practical prescribing considerations

How orforglipron differs from other oral GLP-1 options in terms of administration requirements and prescribing in practice.

Dose escalation, monitoring, and adverse-effect considerations

Titration approach, monitoring requirements, and managing adverse effects in clinical practice.

Place in current weight-management pathways

How orforglipron fits alongside existing treatment options within UK weight-management care pathways.

Live Q&A with Professor Alexander Miras

Put your questions directly to Professor Miras.